Origin and evolution of SARS-CoV-2

被引:0
|
作者
Isabel Pagani
Silvia Ghezzi
Simone Alberti
Guido Poli
Elisa Vicenzi
机构
[1] San Raffaele Scientific Institute,Viral Pathogenesis and Biosafety Unit, Division of Immunology, Transplantation, and Infectious Diseases
[2] San Raffaele Scientific Institute,Human Immuno
[3] Vita-Salute San Raffaele University School of Medicine,Virology (H.I.V.) Unit, Division of Immunology, Transplantation, and Infectious Diseases
关键词
D O I
暂无
中图分类号
学科分类号
摘要
SARS-CoV-2 is a novel coronavirus that emerged in China at the end of 2019 causing the severe disease known as coronavirus disease 2019 (COVID-19). SARS-CoV-2, as to the previously highly pathogenic human coronaviruses named SARS-CoV, the etiological agent of severe acute respiratory syndrome (SARS), has a zoonotic origin, although SARS-CoV-2 precise chain of animal-to-human transmission remains undefined. Unlike the 2002–2003 pandemic caused by SARS-CoV whose extinction from the human population was achieved in eight months, SARS-CoV-2 has been spreading globally in an immunologically naïve population in an unprecedented manner. The efficient infection and replication of SARS-CoV-2 has resulted in the emergence of viral variants that have become predominant posing concerns about their containment as they are more infectious with variable pathogenicity in respect to the original virus. Although vaccine availability is limiting severe disease and death caused by SARS-CoV-2 infection, its extinction is far to be close and predictable. In this regard, the emersion of the Omicron viral variant in November 2021 was characterized by humoral immune escape and it has reinforced the importance of the global monitoring of SARS-CoV-2 evolution. Given the importance of the SARS-CoV-2 zoonotic origin, it will also be crucial to monitor the animal-human interface to be better prepared to cope with future infections of pandemic potential.
引用
收藏
相关论文
共 50 条
  • [1] Origin and evolution of SARS-CoV-2
    Pagani, Isabel
    Ghezzi, Silvia
    Alberti, Simone
    Poli, Guido
    Vicenzi, Elisa
    [J]. EUROPEAN PHYSICAL JOURNAL PLUS, 2023, 138 (02):
  • [2] On the origin and evolution of SARS-CoV-2
    Singh, Devika
    Yi, Soojin, V
    [J]. EXPERIMENTAL AND MOLECULAR MEDICINE, 2021, 53 (04): : 537 - 547
  • [3] On the origin and evolution of SARS-CoV-2
    Devika Singh
    Soojin V. Yi
    [J]. Experimental & Molecular Medicine, 2021, 53 : 537 - 547
  • [4] On the origin and continuing evolution of SARS-CoV-2
    Tang, Xiaolu
    Wu, Changcheng
    Li, Xiang
    Song, Yuhe
    Yao, Xinmin
    Wu, Xinkai
    Duan, Yuange
    Zhang, Hong
    Wang, Yirong
    Qian, Zhaohui
    Cui, Jie
    Lu, Jian
    [J]. NATIONAL SCIENCE REVIEW, 2020, 7 (06) : 1012 - 1023
  • [5] On the origin and continuing evolution of SARS-CoV-2
    Xiaolu Tang
    Changcheng Wu
    Xiang Li
    Yuhe Song
    Xinmin Yao
    Xinkai Wu
    Yuange Duan
    Hong Zhang
    Yirong Wang
    Zhaohui Qian
    Jie Cui
    Jian Lu
    [J]. National Science Review, 2020, 7 (06) : 1012 - 1023
  • [6] SARS-CoV-2: tracing the origin, tracking the evolution
    Voskarides, Konstantinos
    [J]. BMC MEDICAL GENOMICS, 2022, 15 (01)
  • [7] SARS-CoV-2: tracing the origin, tracking the evolution
    Konstantinos Voskarides
    [J]. BMC Medical Genomics, 15
  • [8] Origin, evolution and global spread of SARS-CoV-2
    Zhukova, Anna
    Blassel, Luc
    Lemoine, Frederic
    Morel, Marie
    Voznica, Jakub
    Gascuel, Olivier
    [J]. COMPTES RENDUS BIOLOGIES, 2021, 344 (01) : 57 - 75
  • [9] SARS-CoV-2: Origin, Evolution, and Targeting Inhibition
    Ning, Shuo
    Yu, Beiming
    Wang, Yanfeng
    Wang, Feng
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [10] The origin of SARS-CoV-2
    Burki, Talha
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (09): : 1018 - 1019